Frequency Historical Balance Sheet
| KRRO Stock | 54.99 1.74 3.27% |
Trend analysis of Frequency Therapeutics balance sheet accounts such as Total Current Liabilities of 18.6 M provides information on Frequency Therapeutics' total assets, liabilities, and equity, which is the actual value of Frequency Therapeutics to its prevalent stockholders. By breaking down trends over time using Frequency Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Frequency Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Frequency Therapeutics is a good buy for the upcoming year.
Frequency |
About Frequency Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Frequency Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Frequency Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Frequency Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Frequency currently owns. An asset can also be divided into two categories, current and non-current.
Frequency Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Frequency Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Frequency Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Frequency Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Frequency Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Frequency Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Frequency Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.At this time, Frequency Therapeutics' Non Currrent Assets Other are very stable compared to the past year. As of the 28th of November 2024, Other Current Assets is likely to grow to about 6.9 M, while Total Assets are likely to drop about 153.3 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 45.6M | 3.1M | 33.2M | 34.6M | Total Assets | 127.6M | 73.7M | 221.7M | 153.3M |
Frequency Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Frequency Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Frequency Therapeutics balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 223.2M | 264.7M | 127.6M | 73.7M | 221.7M | 153.3M | |
| Other Current Liab | 3.4M | 6.7M | 4.2M | 3.2M | 10.2M | 10.7M | |
| Total Current Liabilities | 52.8M | 26.6M | 4.9M | 8.7M | 19.5M | 18.6M | |
| Total Stockholder Equity | 167.4M | 192.5M | (42.2M) | (99.0M) | 169.9M | 178.4M | |
| Property Plant And Equipment Net | 1.8M | 37.8M | 7.1M | 11.9M | 42.8M | 45.0M | |
| Net Debt | (200.2M) | (174.3M) | (37.9M) | (33.2M) | (132.9M) | (126.3M) | |
| Retained Earnings | (68.9M) | (95.4M) | (43.8M) | (101.8M) | (183.0M) | (173.9M) | |
| Accounts Payable | 1.2M | 5.5M | 789K | 2.6M | 7.3M | 7.6M | |
| Cash | 200.2M | 220.3M | 83.5M | 36.3M | 166.2M | 120.5M | |
| Non Current Assets Total | 1.9M | 39.7M | 7.8M | 16.7M | 48.9M | 51.4M | |
| Non Currrent Assets Other | 101.0K | (1.0) | (12.8M) | 228K | 2.7M | 2.8M | |
| Cash And Short Term Investments | 217.4M | 220.3M | 118.5M | 55.2M | 166.2M | 131.6M | |
| Common Stock Shares Outstanding | 616.9K | 645.1K | 4.4M | 255.2K | 1.5M | 1.4M | |
| Liabilities And Stockholders Equity | 223.2M | 264.7M | 127.6M | 73.7M | 221.7M | 153.3M | |
| Non Current Liabilities Total | 3.1M | 45.6M | 164.8M | 164.1M | 32.3M | 30.7M | |
| Other Current Assets | 3.2M | 4.4M | 1.2M | 1.8M | 6.6M | 6.9M | |
| Other Stockholder Equity | 236.2M | 287.8M | 1.6M | 2.8M | 352.9M | 370.6M | |
| Total Liab | 55.9M | 72.2M | 169.8M | 172.8M | 51.8M | 49.2M | |
| Total Current Assets | 221.4M | 225.1M | 119.8M | 57.1M | 172.7M | 134.7M | |
| Common Stock | 14K | 31K | 34K | 5K | 8K | 7.2K |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.53 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.5 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.41 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.36 | MNOV | MediciNova | PairCorr |
| 0.36 | PEPG | PepGen | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.43) | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.